)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
Phase Holographic
Phase Holographic (PHI) investor relations material
Phase Holographic has been delisted
Phase Holographic Q2 25/26 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q2 25/26 earnings summary19 Dec, 2025
Executive summary
Sales declined significantly year-over-year due to the transition of sales from Altium and customer anticipation for the next-generation HoloMonitor, which launched after the quarter ended.
Strategic expansion into the veterinary IVF market for livestock, leveraging core QPI technology, was announced.
The company is focusing on innovation, with the Holomonitor Next Generation launched in December, targeting both core and new market segments.
Financial highlights
Q2 2025/26 net sales were 306 KSEK, down from 2,977 KSEK in Q2 2024/25; YTD net sales were 671 KSEK, down from 4,315 KSEK.
Q2 EBITDA was -5,445 KSEK (vs. -2,789 KSEK prior year); net result was -7,761 KSEK (vs. -3,669 KSEK).
Gross margin improved to 60% in Q2 (from 55%); YTD gross margin was 65% (from 63%).
Earnings per share for Q2 was -0.12 SEK (vs. -0.14 SEK); YTD was -0.26 SEK (vs. -0.37 SEK).
Cash and equivalents at period end were 2,221 KSEK, with total available liquidity (including credits) at 4,221 KSEK.
Outlook and guidance
Management expects future growth as the sales transition completes and the new HoloMonitor platform is adopted.
Expansion into veterinary IVF and regenerative medicine is expected to open new revenue streams, though these require validation and collaboration.
Capital resources are approaching their limits; the board is actively seeking solutions.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Phase Holographic
- Sales fell and losses widened as the company shifted to direct sales and targets regenerative medicine.PHI
Q1 25/26 - Sales growth and improved margins drive strategic expansion into clinical and regenerative markets.PHIQ4 24/25
- Q2 sales surged, but margins narrowed; new CEO and rights issue support commercial expansion.PHIQ2 24/25
- Sales dipped as PHI invested in growth, but margin and market expansion signal future upside.PHIQ1 24/25
- Gross margin and net sales improved as PHI advances in regenerative medicine and global expansion.PHIQ4 23/24
- Sales growth and capital raise drive improved results and expansion in regenerative medicine.PHIQ3 24/25
Phase Holographic
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
Frequently asked questions
Phase Holographic Imaging AB is a Sweden-based company specializing in the development and commercialization of time-lapse cytometry solutions. The company's technology enables label-free, non-invasive imaging and analysis of living cells over extended periods. Its products are used in academic and industrial research for applications in cancer research, drug development, and regenerative medicine. The company is headquartered in Lund, Sweden, and its shares are listed on the Spotlight Stock Market.